Publisher
Springer Science and Business Media LLC
Reference68 articles.
1. Rowinsky E, Eisenhauer E, Chaudhry V, Arbuck S, Donehower R (1993) Clinical toxicities encountered with paclitaxel (Taxol). Semin Oncol 20:1–15
2. Nowak AK, Wilcken NR, Stockler MR, Hamilton A, Ghersi D (2004) Systematic review of taxane-containing versus non-taxane-containing regimens for adjuvant and neoadjuvant treatment of early Breast cancer. Lancet Oncol 5:372–380
3. Greco FA (2001) Paclitaxel-based combination chemotherapy in advanced non-small cell Lung cancer. Lung Cancer 34:53–56
4. Sousa-Pimenta M, Estevinho LM, Szopa A, Basit M, Khan K, Armaghan M, Ibrayeva M, Sönmez Gürer E, Calina D, Hano C, Sharifi-Rad J (2023) Chemotherapeutic properties and side-effects associated with the clinical practice of terpene alkaloids: paclitaxel, docetaxel, and cabazitaxel. Front Pharmacol 14:1157306
5. Kale VP, Habib H, Chitren R, Patel M, Pramanik KC, Jonnalagadda SC, Challagundla K, Pandey MK (2021) Old drugs, new uses: Drug repurposing in hematological malignancies. Seminars in cancer biology. Elsevier, Amsterdam, pp 242–248
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献